Poland – Pharmaceutical products – 24_2026 Dostawa produktów leczniczych, w tym leków stosowanych w ramach chemioterapii i programów lekowych

1. The subject of the contract is the supply of medicinal products used in the context of chemotherapy and drug programs. 2. A detailed description of the subject of the contract, including information on the assortment, quantities and its requirements, has been specified in the price form, which is Annex 2 to the SWZ, in which the Purchaser requires the commercial name of the drug to be stated. 3. The validity period of the offered subject of the contract must not be shorter than 6 months from the date of each delivery. 4. The offered subject of the contract must be authorised for the marketing of medicinal products in accordance with the provisions of the Act of 6 September 2001 - Pharmaceutical Law. 5. The subject of the contract will be delivered at the cost, risk and transport of the Contractor. 6. The Purchaser requires that the medicinal products offered by the Contractor be placed in the catalogue of reimbursed drugs used in chemotherapy or the catalogue of reimbursed drugs used in drug programs (compliance of EAN codes), in accordance with the announcement of the Minister of Health issued on the basis of Article 37(1) of the Act of 12 May 2011 on the reimbursement of drugs, special dietary foods and medical devices (Parts 4-11). 7. The Purchaser allows a drug with final import – Part 4, a drug with emergency import (DOP) – Part 3. 8. The Purchaser allows a change in the form of the proposed preparations: - tablets to coated tablets or capsules or dragees and vice versa - vials to ampoules and vice versa - ampoule syringes to injectors. 9. The Purchaser specifies the following rules regarding the change in the size of the offered packages: - in the event of differences between the quantity of products listed in the SWZ and the quantity offered by the Contractor, the number of packages should be rounded up to full packages when converting the quantity of packages. 10. If, during the term of the contract, the Minister of Health withdraws the decision to include the offered product in the reimbursement, the Purchaser may terminate the contract with the Contractor, if the inclusion of the offered product in the reimbursement was a condition for submitting a valid tender offer. 11. The Purchaser indicates that the purchases of the ordered products are dependent on the number of patients enrolled in the program. In the event that there is no demand for a given drug, the Hospital may use Article 456 and terminate the contract as not being in the public interest. Such a situation occurs in Part 7. 12. The Purchaser does not impose any restrictions on the origin of the Contractor or the subject of the contract in terms of market access and participation in this procedure.